Measuring Product-Led Value Creation Beyond Activity, Opinion and Design Output

Executive Summary

Private equity boards do not need more product-development activity reports.

They need evidence that product decisions are improving the economics, competitiveness and future value of the portfolio company.

A conventional product dashboard may report:

Projects completed
Features delivered
Prototypes produced
Engineering hours
Development expenditure
Patents filed
Launch dates

These indicators describe activity.

They do not necessarily demonstrate value creation.

A private equity board needs to understand:

Is product gross margin improving?
Is development capital producing profitable growth?
Is time-to-market becoming shorter?
Is the product portfolio becoming more valuable and less complex?
Is product-market fit becoming stronger?
Are new products producing revenue and margin?
Is pricing power increasing?
Are product risks being identified before appearing in financial reporting?
Is the Product Value Creation Plan progressing according to the investment thesis?
How much of the identified product value has actually been captured?

SARDI PRO CAPITAL measures product performance as a value-creation system connecting product evidence, operational execution and financial outcomes.

The objective is not to attribute every movement in enterprise value to a single product initiative.

The objective is to give investors a credible, measurable and decision-relevant view of how the product system is contributing to investment performance.

The Problem With Traditional Product Metrics

Product development is difficult to measure because companies must balance customer needs, features, technology, cost, risk, portfolio fit and time-to-market while allocating limited resources across competing projects. McKinsey found that product volume, product revenue, unit cost and time-to-market were among the most widely used product-development indicators in its research sample. However, the research also warned that relying on a limited set of short-term product metrics can produce an incomplete view of long-term performance.

This is particularly important in private equity.

A metric may be operationally correct but financially irrelevant.

For example:

A project can be delivered on time but address the wrong market.
A product can achieve its cost target but lose customer value.
A new product can generate revenue but produce weak margins.
An engineering team can remain within budget while developing a commercially irrelevant product.
A roadmap can contain many initiatives while allocating capital poorly.
A prototype can test successfully without creating a scalable business opportunity.

The board therefore needs a connected chain of evidence:

Product activity → operational improvement → economic outcome → investment relevance

A metric that cannot be connected to that chain may still be useful to management, but it does not necessarily belong in the private equity board pack.

What Private Equity Boards Actually Need to Measure

The SARDI PRO CAPITAL measurement model separates indicators into four levels:

Financial Value Metrics
Product and Operating Metrics
Strategic Leading Indicators
Value-Capture and Governance Metrics

The four levels must remain connected.

Financial metrics show whether value has materialised.

Operating metrics explain how the product system is changing.

Leading indicators reveal whether future value creation is becoming more or less probable.

Governance metrics show whether the plan is being executed with sufficient ownership, evidence and control.

1. Financial Value Metrics

These are the outcomes most directly relevant to the investment thesis.

Product Gross-Margin Uplift

Definition: Change in gross margin attributable or credibly linked to product-related initiatives.

The calculation can include:

Lower material cost
Reduced component count
Lower manufacturing cost
Product simplification
Reduced customisation
Improved product mix
Higher pricing
Premium configurations
Lower warranty and service cost

The board should see both:

Margin opportunity identified
Margin improvement realised

A theoretical saving is not equivalent to captured value.

Annualised EBITDA Contribution

Definition: Estimated annual EBITDA contribution from implemented product initiatives.

Examples include:

Gross-margin improvement
Revenue from newly launched products
Reduced product-development expenditure
Lower product complexity
Reduced quality costs
Lower inventory or service burden

The calculation should distinguish:

Validated value
Implemented value
Realised value
Annualised run-rate value

This prevents early-stage opportunities from being reported as if they had already reached the income statement.

Product Cost Reduction

Definition: Reduction in the fully loaded cost of producing, delivering, supporting and maintaining the product.

Unit-cost reduction alone can be misleading.

A credible calculation may need to include:

Bill of materials
Production time
Tooling
Assembly
Quality control
Packaging
Logistics
Installation
Training
Warranty
Service
Product-specific inventory

Kearney’s private-equity product work explicitly connects product design, feature-cost analysis, materials, manufacturing processes and design-to-value with cost and margin improvement.

Revenue From New or Substantially Improved Products

Definition: Percentage and absolute value of revenue generated by products introduced or materially transformed during a defined period.

The definition of “new” must be fixed in advance.

Changing a colour, component or model number should not automatically qualify as product innovation.

The board should also examine:

Revenue quality
Gross margin
Cannibalisation
Repeat demand
Sales concentration
Incrementality

New-product revenue without profitable conversion can create growth without sufficient value.

New-Product-to-Margin Conversion

Definition: Gross margin generated from new-product revenue.

McKinsey proposes examining how effectively new-product sales convert into gross margin rather than measuring innovation only through expenditure, launches or revenue. It also proposes looking at how R&D expenditure converts into new-product sales at portfolio level.

For a PE board, this produces two useful questions:

How much new-product revenue is generated for every unit of development investment?

How much gross margin is generated from that new-product revenue?

These metrics expose innovation that looks productive but does not convert into economic performance.

Pricing-Power Improvement

Definition: Improvement in realised price that can be sustained because of stronger product value or differentiation.

Relevant indicators may include:

Average selling-price increase
Reduction in discounting
Premium product mix
Price realisation against list price
Customer willingness to pay
Win rate at increased price levels
Margin retained after pricing changes

Pricing power must be separated from inflationary pass-through or temporary scarcity.

Product-Related Working-Capital Improvement

Definition: Working-capital improvement resulting from changes to product architecture or portfolio complexity.

Product decisions can affect:

Number of components
Number of suppliers
Inventory levels
Slow-moving stock
Product variants
Spare parts
Forecasting complexity
Minimum production quantities

A product simplification initiative may therefore create value beyond unit cost.

2. Product and Operating Metrics

These metrics explain whether the underlying product system is becoming more capable.

Time-to-Market

Definition: Time from an agreed decision point to validated commercial availability.

The starting point must be explicit:

Opportunity approval
Product brief
Development funding
Design freeze
Prototype approval

The endpoint must also be explicit:

First production unit
Customer validation
Commercial launch
First revenue
Scaled production

Without fixed definitions, organisations can appear faster simply by moving the measurement boundaries.

Time-to-Validated-Concept

Definition: Time required to transform a product opportunity into a concept supported by market, technical and economic evidence.

This is often more useful than measuring only total development time.

A portfolio company may lose months before formal engineering begins because:

Decisions remain unresolved
Customer evidence is missing
Stakeholders disagree
Requirements continue changing
Too many concepts remain alive
Product ownership is unclear

SARDI PRO CAPITAL measures the speed of reducing uncertainty, not only the speed of producing drawings.

Development-Cycle Compression

Definition: Percentage reduction in development cycle time compared with a credible historical baseline.

The comparison should control for:

Product complexity
Regulatory requirements
Engineering novelty
Team capacity
Supplier dependency
Industrialisation requirements

Claims of acceleration become credible only when the baseline and project comparability are transparent.

Launch Reliability

Definition: Percentage of product programmes reaching agreed launch milestones within the planned time, investment and performance range.

This can include:

Schedule adherence
Cost adherence
Technical performance
Manufacturing readiness
Supplier readiness
Commercial readiness
Customer validation

The objective is not perfect adherence to an obsolete plan.

The objective is controlled execution with rapid and explicit decisions when evidence changes.

Design-to-Value Pipeline

Definition: Total identified, validated, implemented and realised value from product redesign and product-economics initiatives.

The board should see a value funnel:

Stage	Meaning
Identified	Potential opportunity detected
Analysed	Technical and economic logic established
Validated	Evidence supports feasibility and customer acceptability
Approved	Management authorises implementation
Implemented	Change incorporated into product or operations
Realised	Economic benefit appears in actual performance

This prevents opportunity estimates from being confused with realised impact.

Product-Portfolio Complexity

Definition: Economic and operational burden created by the number and variability of products, SKUs, components and configurations.

Possible indicators include:

Revenue per SKU
Gross margin per SKU
Low-volume SKU percentage
Component commonality
Number of unique components
Engineering hours consumed by variants
Inventory per product family
Customisation cost
Service complexity

The objective is not always to reduce the product range.

The objective is to determine whether complexity creates customer value or merely internal cost.

Product-Quality Economics

Definition: Financial impact of failures related to the product.

Relevant indicators include:

Warranty cost
Returns
Rework
Scrap
Installation failures
Service interventions
Product-related customer complaints
Cost of non-quality
Lost sales caused by reliability issues

Quality should be connected to economic consequences, not treated only as a technical score.

3. Strategic Leading Indicators

These metrics indicate whether future product-led value creation is becoming more probable.

Product-Market-Fit Evidence

Product-market fit should not be reduced to a subjective management opinion.

Evidence can include:

Validated customer problems
Buying-criteria relevance
Customer willingness to pay
Competitive switching behaviour
Product usage
Repeat purchases
Product adoption
Sales conversion
Customer retention
Evidence from different stakeholder groups

For industrial B2B products, the user, purchaser, technical evaluator, maintenance team and economic decision-maker may be different people.

SARDI PRO CAPITAL therefore evaluates stakeholder fit, not only end-user preference.

Product Differentiation Strength

Definition: Degree to which the product provides valuable, defensible and economically relevant differences compared with alternatives.

The board should distinguish:

Technical difference
Visible difference
Customer-valued difference
Purchasable difference
Defensible difference

A technically unique feature is not automatically a source of enterprise value.

Roadmap Investment Quality

Definition: Percentage of product-development resources allocated to initiatives supported by strategic, market and economic evidence.

Possible indicators include:

Development investment aligned with the Value Creation Plan
Resources allocated to high-priority initiatives
Resources consumed by legacy commitments
Number of unsupported roadmap projects
Expected value by initiative
Risk-adjusted portfolio value
Balance between core, adjacent and transformational initiatives

McKinsey notes that product-development measurement should help organisations allocate time, people and capital to projects that support short- and long-term strategic goals.

Opportunity Validation Rate

Definition: Percentage of investigated product opportunities that reach a defined evidence threshold.

A low rate is not automatically negative.

A disciplined process should eliminate weak opportunities before major capital is committed.

The more important indicators may be:

Time required to reject weak ideas
Cost of validation
Evidence quality
Capital avoided
Quality of approved opportunities

Customer Value per Product Cost

Definition: Relationship between the customer value created by a product characteristic and the cost required to deliver it.

This helps identify:

Expensive features customers do not value
Underpriced high-value features
Product elements that deserve investment
Product elements that can be simplified
Opportunities for premium variants

It provides a direct bridge between customer intelligence and design-to-value.

Product-Risk Visibility

Definition: Percentage of material product risks identified, assigned, mitigated and reported before they become financial problems.

Risk categories may include:

Product obsolescence
Regulatory exposure
Supplier dependency
Technology dependency
Weak intellectual property
Product-market-fit erosion
Quality risk
Roadmap delay
Key-person dependency
Unsustainable customisation

For investors, this is a critical product-intelligence metric.

4. Value-Capture and Governance Metrics

Private equity boards require more than performance indicators.

They require control over the Value Creation Plan.

PwC describes a credible value creation plan as a quantified set of prioritised initiatives supported by capabilities, resources, accountabilities, operating and financial metrics, and governance.

Product Value Identified

Total credible economic opportunity identified through product initiatives.

This is a pipeline metric, not realised performance.

Product Value Approved

Value associated with initiatives formally approved by management and the sponsor.

This confirms commitment but not implementation.

Product Value Implemented

Value associated with changes that have been physically or operationally executed.

Product Value Realised

Value visible in financial or operating results against the agreed baseline.

This is the most important stage.

Value-Capture Rate

Formula:

Realised product value ÷ validated product-value opportunity

This shows how effectively the organisation converts opportunity into results.

Initiative Delivery Confidence

Each material initiative can be classified according to:

Economic confidence
Technical confidence
Market confidence
Execution confidence
Timing confidence

A single green, amber or red status often hides the real source of uncertainty.

Decision Velocity

Definition: Time required to resolve product decisions that materially affect value creation.

Examples include:

Product-priority decisions
Design approvals
Investment approvals
Supplier selection
Scope changes
Stop-or-continue decisions

Slow governance can destroy more value than slow engineering.

Management Adoption

Definition: Degree to which portfolio company leadership and relevant teams have incorporated the Product Value Creation Plan into normal operations.

Possible evidence includes:

Named initiative owners
Resource allocation
Governance attendance
Decisions completed
Processes adopted
Data supplied
Internal capability developed

An external partner cannot create sustainable value if the operating organisation does not absorb the changes.

The SARDI PRO CAPITAL Board Scorecard

A board-level scorecard should remain concise.

A recommended monthly or quarterly dashboard could contain twelve core indicators.

Financial Outcomes

Realised product gross-margin uplift
Annualised EBITDA contribution
New-product revenue
New-product gross margin

Execution Indicators

Time-to-market
Development-cycle compression
Design-to-value implementation rate
Launch reliability

Strategic Indicators

Product-market-fit evidence
Roadmap investment quality
Product-portfolio complexity
Product-risk visibility

Each metric should show:

Baseline
Current position
Target
Variance
Trend
Initiative owner
Expected economic impact
Confidence level
Required board decision

A number without ownership or decision relevance is not a board metric.

Measuring SARDI PRO CAPITAL’s Performance

SARDI PRO CAPITAL’s own performance must be measured separately from the overall company outcome.

SARDI PRO CAPITAL should not claim ownership of every movement in revenue, EBITDA or enterprise value.

Those outcomes are influenced by:

Market conditions
Management decisions
Commercial execution
Pricing
Supply chain
Macroeconomics
Capital availability
Competitor actions
Regulatory changes

A credible Product Operating Partner distinguishes attribution from contribution.

SARDI PRO CAPITAL’s performance can be measured through:

Speed to Product Insight

Time required to produce decision-relevant evidence about product risks and opportunities.

Opportunity Quality

Economic value and validation quality of product opportunities identified.

Initiative Conversion Rate

Percentage of validated initiatives approved and implemented.

Time-to-Execution

Time from initiative approval to operational implementation.

Value-Capture Performance

Realised value compared with the agreed Product Value Creation Plan.

Forecast Accuracy

Accuracy of expected cost, timing, technical performance and economic effect.

Sponsor Visibility

Quality, regularity and decision relevance of investor-grade product intelligence.

Management Integration

Degree of effective collaboration with portfolio company leadership and teams.

Capability Transfer

Extent to which the portfolio company becomes better able to manage product strategy and execution independently.

Skin-in-the-Game Performance

Results attached to the specific milestones or economic outcomes defined in the commercial agreement.

Skin in the Game Requires Better Metrics

A performance-linked commercial model is credible only when measurement is credible.

SARDI PRO CAPITAL’s skin-in-the-game model should therefore define:

Starting baseline
Target outcome
Measurement period
Data source
Calculation method
Initiative ownership
External dependencies
Attribution rules
Approval authority
Payment trigger

For example, a gross-margin improvement agreement should specify whether the baseline includes:

Commodity-price changes
Currency effects
Volume effects
Product-mix changes
Supplier renegotiation
Product redesign
Pricing actions

Without this discipline, “performance-based” compensation can produce conflict rather than alignment.

The FORMULA SARDI Measurement Principle

FORMULA SARDI applies a scientific mindset to product-led value creation.

The relevant sequence is:

Establish the baseline.
Make assumptions explicit.
Identify the variables affecting performance.
Formulate product hypotheses.
Gather market, technical and economic evidence.
Design alternative interventions.
Validate before major investment.
Execute with defined ownership.
Measure operational change.
Confirm economic value captured.

The method prevents product decisions from being judged principally through taste, seniority or internal politics.

It also prevents investors from receiving confident-looking numbers without an evidence chain.

A product metric is credible only when its definition, baseline, cause and economic relevance are visible.

What Private Equity Boards Should Not Accept

Vanity Metrics

Examples:

Number of ideas
Number of workshops
Number of concepts
Number of features
Number of patents
Number of customer interviews

These may support the process, but they do not demonstrate value creation independently.

Unqualified Pipeline Value

An opportunity estimate should never be presented as realised EBITDA.

Revenue Without Margin

New products can create revenue while diluting profitability.

Speed Without Relevance

Faster development creates little value when the wrong product reaches the market sooner.

Cost Reduction Without Customer Evidence

Removing cost can destroy pricing power, quality or product-market fit.

Aggregate Metrics Without Product-Level Visibility

Portfolio averages can hide unprofitable products, weak SKUs and value-destroying complexity.

Targets Without Baselines

Improvement cannot be demonstrated without a credible starting point.

Outcomes Without Ownership

Every material indicator must have an accountable owner.

From Product Reporting to Investor Control

The purpose of product metrics is not to make the board manage engineering.

The purpose is to give the board control over the product-related assumptions and initiatives embedded in the investment thesis.

SARDI PRO CAPITAL provides the product layer required to connect:

Product reality
Market evidence
Operational execution
Financial performance
Enterprise value

Private equity firms already possess exceptional financial and strategic measurement capabilities.

SARDI PRO CAPITAL brings equivalent discipline to the physical side of those numbers.

Investors see the economic outputs. SARDI PRO CAPITAL measures and improves the product system producing them.

Key Takeaways

Product activity is not the same as product value creation.
PE boards need metrics connected to margin, growth, risk and enterprise value.
Financial, operating, strategic and governance indicators must be connected.
New-product revenue should be evaluated together with gross-margin conversion.
Time-to-market requires fixed starting and finishing definitions.
Identified value must be separated from approved, implemented and realised value.
Product-market fit must be evidence-based.
Product complexity should be measured economically.
SARDI PRO CAPITAL’s contribution must be distinguished from total company performance.
Skin in the game requires transparent baselines, attribution rules and measurement methods.

Frequently Asked Questions

What product metrics are most relevant to private equity boards?

The most relevant metrics connect product decisions to gross margin, EBITDA, profitable revenue, development speed, pricing power, product-market fit, portfolio complexity, risk and enterprise value.

What is the difference between leading and lagging product indicators?

Leading indicators provide evidence about future performance, such as product-market fit, roadmap quality and validation progress. Lagging indicators show realised outcomes, such as revenue, gross margin and warranty cost.

How should product-led value creation be measured?

Product-led value creation should be measured from a defined baseline through a chain connecting product intervention, operational effect and realised economic outcome.

Is new-product revenue sufficient to measure innovation performance?

No. New-product revenue should be evaluated together with development investment, gross margin, incrementality, cannibalisation and repeat demand.

How does SARDI PRO CAPITAL measure margin improvement?

SARDI PRO CAPITAL can measure validated and realised improvements arising from product architecture, materials, component reduction, manufacturing, product mix, pricing, complexity and quality costs.

Can SARDI PRO CAPITAL’s impact on enterprise value be calculated precisely?

Not in isolation. Enterprise value is affected by many variables. SARDI PRO CAPITAL can measure its contribution to defined operating and financial value drivers and incorporate them into the sponsor’s broader value bridge.

What metrics support a skin-in-the-game business model?

Suitable metrics include realised gross-margin improvement, annualised EBITDA contribution, development-cycle reduction, launch milestones and other outcomes whose baseline, ownership and calculation method are agreed in advance.

About Enrique Luis Sardi

Enrique Luis Sardi is an entrepreneur, strategic designer and founder of SARDI.

His work focuses on industrial product strategy, stakeholder-centred product development, product intelligence and the creation of innovative physical products for B2B companies.

Through SARDI and FORMULA SARDI, Enrique Luis Sardi has developed an evidence-led approach connecting market relevance, product strategy, physical execution and business value.

About SARDI PRO CAPITAL

Founded by entrepreneurs Enrique Luis Sardi and Adrian Soto, SARDI PRO CAPITAL is a specialised spin-off of SARDI.

SARDI PRO CAPITAL is the Product Operating Partner for private equity firms and product-centred portfolio companies.

SARDI PRO CAPITAL connects product intelligence, product strategy and hands-on execution to measurable improvements in margin, development speed, product-market fit, profitable growth and enterprise value.

SARDI PRO CAPITAL — The Product Side of Investment Performance.

THE PRODUCT METRICS PRIVATE EQUITY BOARDS ACTUALLY NEED TO SEE